Abstract:A large proportion of genetic variations involved in complex diseases are rare and located within non-coding regions, making the interpretation of underlying biological mechanisms a daunting task. Although technical and methodological progresses have been made to annotate the genome, current disease - rare-variant association tests incorporating such annotations suffer from two major limitations. Firstly, they are generally restricted to case-control designs of unrelated individuals, which often require tens or hundreds of thousands of individuals to achieve sufficient power. Secondly, they were not evaluated with region-based annotations needed to interpret the causal regulatory mechanisms. In this work we propose RetroFun-RVS, a new retrospective family-based score test, incorporating functional annotations. One of the critical features of the proposed method is to aggregate genotypes while measuring rare variant sharing among affected family members to compute the test statistic. Through extensive simulations, we have demonstrated that RetroFun-RVS integrating networks based on 3D genome contacts as functional annotations reaches greater power over the region-wide test, other strategies to include sub-regions and competing methods. Also, the proposed framework shows robustness to non-informative annotations, keeping a stable power when causal variants are spread across regions. We provide recommendations when dealing with different types of annotations or family structures commonly encountered in practice. Application of RetroFun-RVS is illustrated on whole genome sequence in the Eastern Quebec Schizophrenia and Bipolar Disorder Kindred Study with networks constructed from 3D contacts and epigenetic data on neurons. In summary we argue that RetroFun-RVS, by allowing integration of functional annotations corresponding to regions or networks with transcriptional impacts, is a useful framework to highlight regulatory mechanisms involved in complex diseases.

RetroFun-RVS: a retrospective family-based framework for rare variant analysis incorporating functional annotations

Mapping structural variants to rare disease genes using long-read whole genome sequencing and trait-relevant polygenic scores

Methods for Association Analysis and Meta‐Analysis of Rare Variants in Families

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Population structure analysis using rare and common functional variants

Inferring disease risk genes from sequencing data in multiplex pedigrees through sharing of rare variants

RVTESTS: an Efficient and Comprehensive Tool for Rare Variant Association Analysis Using Sequence Data.

A Novel Method, the Variant Impact on Linkage Effect Test (VIOLET), Leads to Improved Identification of Causal Variants in Linkage Regions

Efficient Utilization of Rare Variants for Detection of Disease-Related Genomic Regions

Integration of transcriptomics and long-read genomics prioritizes structural variants in rare disease

Approach of Fusing Multiple Tests to Analyzing Rare Genetic Variants

A Probabilistic Method for Identifying Rare Variants Underlying Complex Traits

Leveraging functional annotations to map rare variants associated with Alzheimer's disease with gruyere

The functional impact of rare variation across the regulatory cascade

Rare coding variant analysis for human diseases across biobanks and ancestries

Statistics to prioritize rare variants in family-based sequencing studies with disease subtypes

Detecting functional rare variants by collapsing and incorporating functional annotation in Genetic Analysis Workshop 17 mini-exome data

Meta-analysis of Gene-Level Tests for Rare Variant Association.

A Novel Statistical Method for Interpreting the Pathogenicity of Rare Variants

Functional gene embeddings improve rare variant polygenic risk scores

[Family-Based Association Tests for Rare Variants].